Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 21, 2026
- Accession no.
- 0001106578-26-000145
- Filed
- Sep 21, 2026, 4:44 PM ET
- Trade date
- Sep 18, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.70M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −248 | $492.91F3 | −$122,240.51 | 333,695 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −2,216 | $493.78F4 | −$1,094,209.39 | 331,479 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −4,269 | $494.70F5 | −$2,111,871.31 | 327,210 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −2,330 | $495.66F6 | −$1,154,894.32 | 324,880 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −277 | $496.64F7 | −$137,569.14 | 324,603 | Indirect | |
| Sep 18, 2026 | Common Stock | SSaleDisposed | −160 | $498.25 | −$79,720 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 404,410 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $492.24 to $493.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $493.29 to $494.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $494.30 to $495.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $495.30 to $496.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $496.35 to $497.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.